1. A co‐formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Issue 5 (31st January 2023) Authors: Andersen, Grit; Eloy, Rosy; Famulla, Susanne; Heise, Tim; Meiffren, Grégory; Seroussi, Cyril; Gaudier, Martin; Mégret, Claire; Chan, You‐Ping; Soula, Olivier; Riddle, Matthew Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 5(2023) Page Start: 1241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes. Issue 4 (18th January 2021) Authors: Andersen, Grit; Meiffren, Grégory; Famulla, Susanne; Heise, Tim; Ranson, Aymeric; Seroussi, Cyril; Eloy, Rosy; Gaudier, Martin; Charvet, Richard; Chan, You‐Ping; Soula, Olivier; DeVries, J. Hans Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 4(2021) Page Start: 961 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cover Image, Volume 23, Issue 3. Issue 4 (18th March 2021) Authors: Andersen, Grit; Famulla, Susanne; Heise, Tim; Ranson, Aymeric; Seroussi, Cyril; Eloy, Rosy; Gaudier, Martin; Charvet, Richard; Chan, You‐Ping; Soula, Olivier; DeVries, J. Hans Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cover Image, Volume 23, Issue 4. Issue 4 (18th March 2021) Authors: Andersen, Grit; Meiffren, Grégory; Famulla, Susanne; Heise, Tim; Ranson, Aymeric; Seroussi, Cyril; Eloy, Rosy; Gaudier, Martin; Charvet, Richard; Chan, You‐Ping; Soula, Olivier; DeVries, J. Hans Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cover Image. Issue 5 (2nd April 2023) Authors: Andersen, Grit; Eloy, Rosy; Famulla, Susanne; Heise, Tim; Meiffren, Grégory; Seroussi, Cyril; Gaudier, Martin; Mégret, Claire; Chan, You‐Ping; Soula, Olivier; Riddle, Matthew Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 5(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Editorial: evolution of GLP‐1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity – authors' reply. Issue 11 (6th November 2021) Authors: Flint, Anne; Andersen, Grit; Hockings, Paul; Plum‐Mörschel, Leona; Loomba, Rohit Journal: Alimentary pharmacology & therapeutics Issue: Volume 54:Issue 11/12(2021) Page Start: 1498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects on α‐ and β‐cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study. Issue 4 (10th January 2017) Authors: Forst, Thomas; Falk, Alexander; Andersen, Grit; Fischer, Annelie; Weber, Matthias M.; Voswinkel, Stephan; Heise, Tim; Kapitza, Christoph; Plum‐Mörschel, Leona Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 4(2017) Page Start: 489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Endothelial‐protective effects of a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist, SAR247799, in type‐2 diabetes rats and a randomized placebo‐controlled patient trial. Issue 5 (26th November 2020) Authors: Bergougnan, Luc; Andersen, Grit; Plum‐Mörschel, Leona; Evaristi, Maria Francesca; Poirier, Bruno; Tardat, Agnes; Ermer, Marcel; Herbrand, Theresa; Arrubla, Jorge; Coester, Hans Veit; Sansone, Roberto; Heiss, Christian; Vitse, Olivier; Hurbin, Fabrice; Boiron, Rania; Benain, Xavier; Radzik, David;... Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 5(2021) Page Start: 2303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging. Issue 9 (27th September 2021) Authors: Flint, Anne; Andersen, Grit; Hockings, Paul; Johansson, Lars; Morsing, Anni; Sundby Palle, Mads; Vogl, Thomas; Loomba, Rohit; Plum‐Mörschel, Leona Journal: Alimentary pharmacology & therapeutics Issue: Volume 54:Issue 9(2021) Page Start: 1150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes. Issue 11 (12th July 2018) Authors: Andersen, Grit; Meiffren, Grégory; Lamers, Daniela; DeVries, J. Hans; Ranson, Aymeric; Seroussi, Cyril; Alluis, Bertrand; Gaudier, Martin; Soula, Olivier; Heise, Tim Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 11(2018) Page Start: 2627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗